These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23504289)

  • 1. Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model.
    Philippens IH; Wubben JA; Finsen B; 't Hart BA
    J Neuroimmune Pharmacol; 2013 Jun; 8(3):715-26. PubMed ID: 23504289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model.
    Verhave PS; Jongsma MJ; Van Den Berg RM; Vanwersch RA; Smit AB; Philippens IH
    Neuropharmacology; 2012 Mar; 62(4):1700-7. PubMed ID: 22178201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
    Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
    J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model.
    Hou L; Sun F; Huang R; Sun W; Zhang D; Wang Q
    Redox Biol; 2019 Apr; 22():101134. PubMed ID: 30798073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
    Sharma N; Nehru B
    Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Wu DC; Teismann P; Tieu K; Vila M; Jackson-Lewis V; Ischiropoulos H; Przedborski S
    Proc Natl Acad Sci U S A; 2003 May; 100(10):6145-50. PubMed ID: 12721370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Parkinson effects of a selective alpha2C-adrenoceptor antagonist in the MPTP marmoset model.
    Philippens IH; Joosen MJ; Ahnaou A; Andres I; Drinkenburg WP
    Behav Brain Res; 2014 Aug; 269():81-6. PubMed ID: 24769173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols.
    Johnson DK; Schillinger KJ; Kwait DM; Hughes CV; McNamara EJ; Ishmael F; O'Donnell RW; Chang MM; Hogg MG; Dordick JS; Santhanam L; Ziegler LM; Holland JA
    Endothelium; 2002; 9(3):191-203. PubMed ID: 12380644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.
    Zhang D; Hu X; Wei SJ; Liu J; Gao H; Qian L; Wilson B; Liu G; Hong JS
    J Neuroinflammation; 2008 May; 5():21. PubMed ID: 18507839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmoset.
    Hamadjida A; Nuara SG; Kwan C; Frouni I; Bédard D; Gourdon JC; Huot P
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2157-2164. PubMed ID: 32621059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-DOPA-induced behavioral sensitization of motor activity in the MPTP-treated common marmoset as a Parkinson's disease model.
    Ando K; Inoue T; Itoh T
    Pharmacol Biochem Behav; 2014 Dec; 127():62-9. PubMed ID: 25449794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraquat and maneb co-exposure induces noradrenergic locus coeruleus neurodegeneration through NADPH oxidase-mediated microglial activation.
    Hou L; Zhang C; Wang K; Liu X; Wang H; Che Y; Sun F; Zhou X; Zhao X; Wang Q
    Toxicology; 2017 Apr; 380():1-10. PubMed ID: 28202386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apocynin, a low molecular oral treatment for neurodegenerative disease.
    't Hart BA; Copray S; Philippens I
    Biomed Res Int; 2014; 2014():298020. PubMed ID: 25140304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
    van Vliet SA; Blezer EL; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
    Brain Res; 2008 Jan; 1189():219-28. PubMed ID: 18076869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
    Zhang W; Wang T; Qin L; Gao HM; Wilson B; Ali SF; Zhang W; Hong JS; Liu B
    FASEB J; 2004 Mar; 18(3):589-91. PubMed ID: 14734632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23.
    Willis GL; Robertson AD
    Pharmacol Biochem Behav; 2005 Jan; 80(1):9-26. PubMed ID: 15652376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.
    Franke SK; van Kesteren RE; Wubben JA; Hofman S; Paliukhovich I; van der Schors RC; van Nierop P; Smit AB; Philippens IH
    Neuroscience; 2016 Jan; 312():247-59. PubMed ID: 26431624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons.
    Gao HM; Liu B; Hong JS
    J Neurosci; 2003 Jul; 23(15):6181-7. PubMed ID: 12867501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion hippocampus injury in rat brain.
    Kapoor M; Sharma N; Sandhir R; Nehru B
    Biomed Pharmacother; 2018 Jan; 97():458-472. PubMed ID: 29091896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.